Aortoenteric fistula after endovascular mycotic aortic aneurysm exclusion: lessons learned during the COVID-19 era.
Ahmed HassanAazeb KhanBella HuasenMohamed BanihaniPublished in: BMJ case reports (2021)
We report a case of aortoenteric fistula 2 years following endovascular aortic aneurysm repair (EVAR) for mycotic aneurysm presenting as upper gastrointestinal bleeding. Initial CT angiogram did not reveal the bleeding or connection to bowel, but endoscopy was suspicious of endograft in the duodenum. Management required a multidisciplinary approach. To stabilise the patient and to control bleeding, a 'bridging' endograft extension was performed. This was followed by open surgical removal of the EVAR endograft and lower limb in situ revascularisation. During postoperative recovery, the patient developed atypical, staged multisystemic symptoms (cardiac, pulmonary and neurological). With increasing awareness of the COVID-19 pandemic, the patient was found SARS-CoV-2-positive, which explained the progression of his symptoms. This was also reflected on other case reports in literature later.
Keyphrases
- sars cov
- case report
- lower limb
- left ventricular
- aortic aneurysm
- systematic review
- atrial fibrillation
- computed tomography
- coronary artery
- abdominal aortic
- patients undergoing
- minimally invasive
- gene expression
- aortic dissection
- magnetic resonance imaging
- heart failure
- magnetic resonance
- single cell
- genome wide
- pulmonary artery
- physical activity